Literature DB >> 19401280

Cardiorenal syndrome in decompensated heart failure.

W H Wilson Tang1, Wilfried Mullens.   

Abstract

Worsening renal function during treatment of acute decompensated heart failure (ADHF) often complicates the treatment course of heart failure. Furthermore, the development of worsening renal function is a strong independent predictor of long-term adverse outcomes. Sometimes referred to as 'cardiorenal syndrome,' the definition varies widely, and the overall understanding of pathogenesis is limited. This is probably owing to the lack of precision and characterisation of renal compromise during treatment of heart failure. Traditionally, the predominant cause has been attributed to impairment of cardiac output and relative underfilling of arterial perfusion. Emerging data have led to a resurgence of interest in the importance of venous congestion and elevated intra-abdominal pressure rather than confining it to impaired forward cardiac output as the primary driver of renal impairment. These revived concepts may support the role of novel renal-sparing approaches to salt and water removal and renal preservation, but better ways to distinguish haemodynamic versus other nephrotoxic aetiologies are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19401280     DOI: 10.1136/hrt.2009.166256

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  41 in total

1.  The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing.

Authors:  Qiaoxiang Yin; Yusheng Zhao; Jiayue Li; Qiao Xue; Xingli Wu; Lei Gao; Ping He; Mei Zhu; Shiwen Wang
Journal:  Clin Cardiol       Date:  2011-05-31       Impact factor: 2.882

2.  [Cardiorenal syndrome].

Authors:  M D Alscher; U Sechtem
Journal:  Internist (Berl)       Date:  2012-03       Impact factor: 0.743

Review 3.  [Acute cardiorenal syndromes].

Authors:  U Janssens; M Joannidis
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-10       Impact factor: 0.840

4.  Cardiorenal syndromes.

Authors:  Peter A McCullough; Aftab Ahmad
Journal:  World J Cardiol       Date:  2011-01-26

5.  Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence.

Authors:  Thierry H Le Jemtel; Indranee Rajapreyar; Michael G Selby; Brian Payne; David R Barnidge; Natasa Milic; Vesna D Garovic
Journal:  Cardiorenal Med       Date:  2015-02-28       Impact factor: 2.041

6.  Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.

Authors:  Uptal D Patel; Melissa A Greiner; Gregg C Fonarow; Hemant Phatak; Adrian F Hernandez; Lesley H Curtis
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

Review 7.  Cardiorenal syndrome: diagnosis, treatment, and clinical outcomes.

Authors:  Kevin Shrestha; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2010-12

8.  Evaluation of serum symmetric dimethylarginine in dogs with heartworm infection.

Authors:  Bom-Sul Choi; Hyeongsun Moon; Sang-Il Suh; Changbaig Hyun
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

9.  The cardiorenal syndrome: making the connection.

Authors:  Gautham Viswanathan; Scott Gilbert
Journal:  Int J Nephrol       Date:  2010-10-04

Review 10.  The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.

Authors:  Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Vasc Res       Date:  2013-04-16       Impact factor: 1.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.